NDC 63736-200

Anacin

Asprin And Caffeine

Anacin is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Insight Pharmaceuticals Llc. The primary component is Aspirin; Caffeine.

Product ID63736-200_11bd624d-b3d5-4ea4-ae24-705364eb2603
NDC63736-200
Product TypeHuman Otc Drug
Proprietary NameAnacin
Generic NameAsprin And Caffeine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-06-25
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameInsight Pharmaceuticals LLC
Substance NameASPIRIN; CAFFEINE
Active Ingredient Strength400 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 63736-200-04

1 BLISTER PACK in 1 BOX (63736-200-04) > 4 TABLET in 1 BLISTER PACK
Marketing Start Date2009-06-25
Marketing End Date2023-06-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63736-200-90 [63736020090]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-95 [63736020095]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-30 [63736020030]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-04 [63736020004]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-92 [63736020092]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-50 [63736020050]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-93 [63736020093]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

NDC 63736-200-91 [63736020091]

Anacin TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2009-06-25

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN400 mg/1

OpenFDA Data

SPL SET ID:51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198479
  • 211292
    • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
    • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
    • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

    • NDC Crossover Matching brand name "Anacin" or generic name "Asprin And Caffeine"

    NDCBrand NameGeneric Name
    63736-200AnacinAsprin and Caffeine
    63736-211AnacinAspirin and Caffeine

    Trademark Results [Anacin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ANACIN
    ANACIN
    72409631 0940857 Live/Registered
    AMERICAN HOME PRODUCTS CORPORATION
    1971-12-13
    ANACIN
    ANACIN
    71485181 0418790 Live/Registered
    WHITEHALL PHARMACAL COMPANY
    1945-06-28
    ANACIN
    ANACIN
    71400284 0356425 Dead/Expired
    ANACIN COMPANY, THE
    1937-11-30
    ANACIN
    ANACIN
    71317967 0290215 Dead/Expired
    ANACIN COMPANY, THE
    1931-08-14
    ANACIN
    ANACIN
    71111064 0123606 Dead/Expired
    KNIGHT, WM. M.
    1918-05-20
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.